MMP9 and coronary artery disorder: In 1127 patients with confirmed coronary artery disease, higher baseline plasma MMP9 concentrations were associated with increased cardiovascular mortality over a mean follow-up of 4.1 years (62.2 ng/mL in fatal events vs. 47.8 ng/mL in survivors; p < 0.0001) [19].